Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delgocitinib vs Alitretinoin in Severe Chronic Hand Eczema
NCT05259722Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Jun 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of delgocitinib in chronic hand eczema (CHE), sponsored by LEO Pharma. Started Jun 2022; status: completed.
02
Drugs
delgocitinib
03
Conditions
chronic hand eczema (CHE)
Beyond the preview
Go deeper on NCT05259722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05259722.